Skip to main content

Complement regulation during pregnancy

Abstract

Complement has an important role in innate immunity and inflammation. Complement also has the capacity to attack self tissues. Cells are protected from the deleterious effects of complement. The Crry protein belongs to a family of molecules that regulates complement activation, protecting tissues from complement-mediated damage. To investigate the role of these molecules in vivo, Crry −/− mice were generated. Crry −/− mice did not survive pregnancy owing to abnormal complement deposition in the placenta through the alternative pathway. Tissue damage related to C5 (production of C5a and C5b-9) was not required. Removal of inflammatory cells did not affect the phenotype. This suggests new noninflammatory mechanisms of pregnancy failure that are dependent solely on C3. The major abnormality was a failure of blood vessel formation in the placenta, revealing an unsuspected C3 effect in the vascular development of this organ.

This is a preview of subscription content, access via your institution.

References

  1. Schmidt BZ, Colten HR: Complement: a critical test of its biological importance. Immunol Rev 2000;178: 166–176.

    PubMed  Article  CAS  Google Scholar 

  2. Molina H: Complement and immunity. Rheum Dis Clin N Am 2004;30:1–18.

    Article  Google Scholar 

  3. Hourcade D, Holers VM, Atkinson JP: The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989;45:381–416.

    PubMed  CAS  Google Scholar 

  4. Lublin DM, Atkinson JP: Decay-accelerating factor and membrane cofactor protein. Curr Top Microbiol Immunol 1989;153:123–145.

    Google Scholar 

  5. Tsujimura A, Shida K, Kitamura M, et al: Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J 1998;330:163–168.

    PubMed  CAS  Google Scholar 

  6. Wong W, Fearon DT: P65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J Immunol 1985;134:4048–4056.

    PubMed  CAS  Google Scholar 

  7. Paul MS, Aegerter M, O’Brien SE, Kurtz CB, Weis JH: The murine complement receptor gene family I: analysis of mCRY gene products and their homology to human CR1. J Immunol 1989;142:582–589.

    PubMed  CAS  Google Scholar 

  8. Molina H, Wong W, Kinoshita T, Brenner C, Foley S, Holers VM: Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J Exp Med 1992;175:121–129.

    PubMed  Article  CAS  Google Scholar 

  9. Kim Y-U, Kinoshita T, Molina H, et al: Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 1995;181: 151–159.

    PubMed  Article  CAS  Google Scholar 

  10. Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H: Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 1990;172:1673–1680.

    PubMed  Article  CAS  Google Scholar 

  11. Seya T, Kojima A, Hara T, Hazeki K, Sugita Y, Akedo H: Enhancement of lymphocyte-mediated K562 cytotoxicity by antibodies against complement membrane cofactor protein (CD46) and decay-accelerating factor (CD55). Immunobiology 1991; 183:115–124.

    PubMed  CAS  Google Scholar 

  12. Quigg RJ, Morgan BP, Holers VM, Adler S, Sneed AE, Lo CF: Complement regulation in rat glomerulus: Crry and CD 59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int 1995;48:412–421.

    PubMed  Article  CAS  Google Scholar 

  13. Nomura A, Nishikawa K, Yuzawa Y, et al: Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 1995;96:2348–2356.

    PubMed  CAS  Article  Google Scholar 

  14. Matsuo S, Ichida S, Takizawa H, et al: In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med 1994;180: 1619–1627.

    PubMed  Article  CAS  Google Scholar 

  15. McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt J: Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. Transplantation 1995;59:1177–1182.

    PubMed  Article  CAS  Google Scholar 

  16. Quigg RJ, Kozono Y, Berthiaume D, et al: Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol 1998:160:4553–4560.

    PubMed  CAS  Google Scholar 

  17. Schiller B, He C, Salant DJ, Lim A, Alexander JJ, Quigg R: Inhibition of complement regulation is key to the pathogenesis of Heymann nephritis. J Exp Med 1998; 188:1353–1358.

    PubMed  Article  CAS  Google Scholar 

  18. Xu C, Mao D, Holers MV, Palanca B, Cheng AM, Molina H: A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 2000;287: 498–501.

    PubMed  Article  CAS  Google Scholar 

  19. Billington WD: The normal fetomaternal immune relationship. Baillière’s Clin Obstet Gynaecol 1992; 6: 417–438.

    Article  CAS  Google Scholar 

  20. Mao D, Wu X, Deppong C, et al: Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 2003;19813–822.

    PubMed  Article  CAS  Google Scholar 

  21. Rinkenberger J, Werb Z: The labyrinthine placental. Nat Genet 2000;25:248–250.

    PubMed  Article  CAS  Google Scholar 

  22. Kingdom J, Huppertz B, Seaward G, Kaufmann P: Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000;92:35–43.

    PubMed  Article  CAS  Google Scholar 

  23. Cross JC: Genetic insights into trophoblast differentiation and placental morphogenesis. Cell Dev Biol 2000; 11:105–113.

    Article  CAS  Google Scholar 

  24. Hill JA: Immunological contributions to recurrent pregnancy loss. Baillière’s Clin Obstet Gynaecol 1992;6: 489–505.

    Article  CAS  Google Scholar 

  25. Vince GS, Johnson PM: Materno-fetal immunobiology in normal pregnancy and its possible failure in recurrent spontaneous abortion? Hum Reprod 1995;10:107–113.

    PubMed  CAS  Google Scholar 

  26. McIntyre JA: Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992;28: 127–131.

    PubMed  CAS  Google Scholar 

  27. Rooney IA, Oglesby TJ, Atkinson JP: Complement in human reproduction: activation and control. Immunol Res 1993;12:276–294.

    PubMed  CAS  Google Scholar 

  28. Holmes CH, Simpson KL: Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship. Baillière’s Clin Obstet Gynaecol 1992;6:439–460.

    Article  CAS  Google Scholar 

  29. Holers VM, Girardi G, Mo L, et al: Complement C3 activation is required for the antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211–220.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Molina, H. Complement regulation during pregnancy. Immunol Res 32, 187–192 (2005). https://doi.org/10.1385/IR:32:1-3:187

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/IR:32:1-3:187

Key Words

  • Complement
  • Complement regulation
  • Pregnancy
  • Fetal loss
  • Innate immunity